Warning: Javascript must be enabled within your browser's settings for this site to function properly.

Your browser appears to be out of date, and is not supported by this site. For the best experience, we recommend that you upgrade to a more modern browser. You can find a list of modern browsers from www.browsehappy.com.

We use technical and analytics cookies data to ensure that we give you the best experience on our website. For more information visit our Privacy Page.

BWXT $   $  
As of . Minimum 20 minute delay.

News

BWXT Announces Expansion of Cambridge Manufacturing Plant to Support Global Nuclear Power Market

19 April 2024

BWX Technologies, Inc. (NYSE: BWXT) announced an investment to expand its Cambridge manufacturing plant.


BWXT Canada Joins Canadians for CANDU® Campaign

11 April 2024

BWXT Canada Ltd., a subsidiary of BWX Technologies, Inc. (NYSE: BWXT), has joined the Canadians for CANDU Campaign.


UK Space Agency Awards Space Reactor Development Project to BWXT and Rolls-Royce

08 April 2024

BWX Technologies, Inc. announced that it and Rolls-Royce have secured funding for Phase 2 of the UK Space Agency’s International Bilateral Fund (IBF).


BWXT Releases 2024 Sustainability Report

14 March 2024

BWX Technologies, Inc. (NYSE: BWXT) has released its 2024 Sustainability Report.


BWXT-led Team Awarded $45 Billion Environmental Management Contract for DOE’s Hanford Site

04 March 2024

BWX Technologies, Inc. announced a contract with an estimated value of up to $45 billion over a 10-year ordering period from the U.S. Department of Energy (DOE) for environmental management operations at the Hanford Site in Washington.


BWX Technologies Reports Fourth Quarter and Full Year 2023 Results, Initiates 2024 Guidance

27 February 2024

BWX Technologies, Inc. (NYSE: BWXT) reported fourth quarter and full year 2023 results.


BWXT Medical Expands Collaboration with Fusion Pharmaceuticals Through Strengthened Actinium Supply and Access to Generator Technology

16 November 2023

(OTTAWA, Ontario – November 16, 2023) – BWXT Medical Ltd. and Fusion Pharmaceuticals Inc. (Nasdaq: FUSN) today announced that the companies have entered into an agreement for the supply of generators to produce actinium-225, a medical isotope used to treat cancer in clinical trials.


BWXT Names Mike Boorstein as New General Manager for Euclid Manufacturing Facility

09 November 2023

(EUCLID, Ohio – November 9, 2023) – BWX Technologies, Inc. (NYSE: BWXT) has appointed Mike Boorstein as the new general manager for its Nuclear Operations Group-Euclid manufacturing facility.


BWXT Selected as Nuclear Fuel and Component Manufacturer for Air Force Research Laboratory’s JETSON Program

08 November 2023

BWX Technologies, Inc. announced that it has been selected as the nuclear fuel and components manufacturer for the Air Force Research Laboratory’s Joint Emergent Technology Supplying On-Orbit Nuclear (JETSON) high power mission application program


Press Contacts:

BWX Technologies, Inc.

Jud Simmons 
+1 434.522.3800
hjsimmons@bwxt.com

BWXT Canada Ltd.
BWXT Nuclear Energy Canada Inc.
BWXT Medical Ltd.

Monifa Miller
+1 519.242.8071
mamiller@bwxt.com 

Nuclear Fuel Services, Inc.

Laura Bailey 
+1 423.743.9141
lebailey@nuclearfuelservices.com 

Archive

Tags